This company has been marked as potentially delisted and may not be actively trading. AzurRx BioPharma (AZRX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock AZRX vs. ABVC, IPA, MEIP, IMNN, PHIO, LSB, RLMD, TXMD, NERV, and QNTMShould you be buying AzurRx BioPharma stock or one of its competitors? The main competitors of AzurRx BioPharma include ABVC BioPharma (ABVC), ImmunoPrecise Antibodies (IPA), MEI Pharma (MEIP), Imunon (IMNN), Phio Pharmaceuticals (PHIO), Lakeshore Biopharma (LSB), Relmada Therapeutics (RLMD), TherapeuticsMD (TXMD), Minerva Neurosciences (NERV), and Quantum Biopharma (QNTM). These companies are all part of the "medical" sector. AzurRx BioPharma vs. ABVC BioPharma ImmunoPrecise Antibodies MEI Pharma Imunon Phio Pharmaceuticals Lakeshore Biopharma Relmada Therapeutics TherapeuticsMD Minerva Neurosciences Quantum Biopharma ABVC BioPharma (NASDAQ:ABVC) and AzurRx BioPharma (NASDAQ:AZRX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk. Does the MarketBeat Community favor ABVC or AZRX? AzurRx BioPharma received 225 more outperform votes than ABVC BioPharma when rated by MarketBeat users. CompanyUnderperformOutperformABVC BioPharmaN/AN/AAzurRx BioPharmaOutperform Votes22574.26% Underperform Votes7825.74% Do insiders & institutionals hold more shares of ABVC or AZRX? 11.4% of ABVC BioPharma shares are held by institutional investors. Comparatively, 6.3% of AzurRx BioPharma shares are held by institutional investors. 11.9% of ABVC BioPharma shares are held by insiders. Comparatively, 7.3% of AzurRx BioPharma shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is ABVC or AZRX more profitable? AzurRx BioPharma has a net margin of 0.00% compared to ABVC BioPharma's net margin of -1,619.65%. ABVC BioPharma's return on equity of -104.94% beat AzurRx BioPharma's return on equity.Company Net Margins Return on Equity Return on Assets ABVC BioPharma-1,619.65% -104.94% -56.81% AzurRx BioPharma N/A -482.96%-258.47% Which has preferable earnings and valuation, ABVC or AZRX? ABVC BioPharma has higher revenue and earnings than AzurRx BioPharma. ABVC BioPharma is trading at a lower price-to-earnings ratio than AzurRx BioPharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioABVC BioPharma$509.59K30.23-$10.52M-$0.47-2.08AzurRx BioPharmaN/AN/A-$32.67M-$11.50-0.03 Which has more volatility & risk, ABVC or AZRX? ABVC BioPharma has a beta of 0.33, indicating that its share price is 67% less volatile than the S&P 500. Comparatively, AzurRx BioPharma has a beta of 1.51, indicating that its share price is 51% more volatile than the S&P 500. Does the media refer more to ABVC or AZRX? In the previous week, ABVC BioPharma had 1 more articles in the media than AzurRx BioPharma. MarketBeat recorded 1 mentions for ABVC BioPharma and 0 mentions for AzurRx BioPharma. ABVC BioPharma's average media sentiment score of 1.87 beat AzurRx BioPharma's score of 0.00 indicating that ABVC BioPharma is being referred to more favorably in the media. Company Overall Sentiment ABVC BioPharma Very Positive AzurRx BioPharma Neutral SummaryABVC BioPharma beats AzurRx BioPharma on 9 of the 13 factors compared between the two stocks. Get AzurRx BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AZRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AZRX vs. The Competition Export to ExcelMetricAzurRx BioPharmaPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.36M$6.68B$5.44B$7.80BDividend YieldN/A3.17%5.43%4.30%P/E Ratio-0.037.1422.1418.40Price / SalesN/A238.89389.70101.29Price / CashN/A65.6738.2034.62Price / Book-0.476.266.664.18Net Income-$32.67M$142.48M$3.21B$247.71M AzurRx BioPharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AZRXAzurRx BioPharmaN/A$0.36-4.4%N/A-87.5%$3.36MN/A-0.0312Gap DownABVCABVC BioPharma1.4366 of 5 stars$0.84-4.3%N/A-38.6%$13.18M$509,788.00-0.9730Positive NewsIPAImmunoPrecise Antibodies2.5734 of 5 stars$0.41+1.7%$4.00+866.2%-63.1%$12.86M$24.00M-0.5380Short Interest ↓MEIPMEI Pharma2.2911 of 5 stars$1.93+0.8%N/A-32.3%$12.83M$65.30M-0.34100Analyst ForecastShort Interest ↑News CoverageIMNNImunon2.3708 of 5 stars$0.87-2.1%$21.50+2,371.3%-39.1%$12.74M$500,000.00-0.4630Short Interest ↓PHIOPhio Pharmaceuticals2.6123 of 5 stars$2.63-7.2%$4.00+52.4%-67.9%$12.54MN/A-0.2410Short Interest ↑Gap DownLSBLakeshore Biopharma1.1097 of 5 stars$1.35+5.1%N/AN/A$12.52M$672.27M0.00773Short Interest ↓Gap UpRLMDRelmada Therapeutics4.2795 of 5 stars$0.37+14.9%$4.25+1,045.6%-82.6%$12.05MN/A-0.1310High Trading VolumeTXMDTherapeuticsMD1.3041 of 5 stars$1.04+4.4%N/A-38.5%$12.04M$1.76M0.00420Analyst ForecastGap DownNERVMinerva Neurosciences3.1133 of 5 stars$1.72+3.4%$5.00+191.4%-27.3%$12MN/A-3.909Upcoming EarningsNegative NewsQNTMQuantum BiopharmaN/A$6.28+0.7%N/AN/A$11.99MN/A-0.41N/APositive News Related Companies and Tools Related Companies ABVC Alternatives IPA Alternatives MEIP Alternatives IMNN Alternatives PHIO Alternatives LSB Alternatives RLMD Alternatives TXMD Alternatives NERV Alternatives QNTM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AZRX) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AzurRx BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AzurRx BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AZRX Stock Free AZRX Stock Alerts